Magnacef (Cefixime) is a semi-synthetic third generation cephalosporin which has a bactericidal action against most strains of organisms including penicillinase producing strains.Magnacef has an average peak plasma concentrations occurring within 4 hrs after oral administration with a half-life of 3-4 hrs. * Indications : Magnacef is indicated for the treatment of: – Upper respiratory tract infections: Otitis media, pharyngitis and tonsillitis. – Lower respiratory tract infections: Acute bronchitis and acute exacerbation of chronic bronchitis. – Uro-genital infections and sexually transmitted diseases such as gonorrhoea. * Presentation• : Magnacef – 200 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 200 mg Cefixime. Blister packs of 8 capsules . Magnacef – 400 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 400 mg Cefixime.Blister packs of 6 ,5 capsules . Magnacef for Oral Suspension: Each 5 ml of reconstituted suspension contains Cefixime Trihydrate USP equivalent to 100 mg Cefixime. Bottles of 30 & 60 ml suspension. Hospital Packs of different sizes are available. •All presentations may not be available in all countries.
وصفة طبية
